U.S., EU Move To Harmonize Drug Approval Scheme

Law360, New York (November 28, 2007, 12:00 AM EST) -- Pharmaceutical industry representatives have urged regulators from the United States and the European Union to better harmonize their drug approval and marketing authorization requirements in order to ease the burden on multinational businesses.

The EC hosted the Transatlantic Administrative Simplification Workshop in Brussels on Wednesday. The U.S. Food and Drug Administration, the European Commission, the European Medicines Agency, advocacy groups and companies attended.

The workshop aimed to set a road map on how best to streamline the way U.S. and European regulators approve medications and marketing...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.